|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net income | |||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||
| Depreciation on premises and equipment | |||
| Core deposit intangible amortization | |||
| Amortization of premiums of debt securities | |||
| Amortization of (discounts) premiums of debt securities | |||
| Accretion of net discounts and deferred loan fees | |||
| Amortization of discounts of debt securities | |||
| (Gain) loss on sale of loans | |||
| Loss on sale and disposal of fixed assets | |||
| Loss on early debt extinguishment | |||
| Loans originated for sale | |||
| Proceeds from sales of and principal collected on loans held for sale | |||
| (Reversal of) provision for credit losses | |||
| Deferred income tax expense (benefit) | |||
| Impairment charges of right-of-use assets | |||
| Stock-based compensation | |||
| Increase in cash surrender value of bank owned life insurance | |||
| Loss on sale of debt securities | |||
| Income from bank owned life insurance | |||
| Loss on sale of other real estate owned | |||
| Valuation allowance on other real estate owned | |||
| Net decrease in other items | |||
| Net cash provided by operating activities | |||
| INVESTING ACTIVITIES | |||
| Net cash acquired in business combination | |||
| Proceeds from bank owned life insurance death benefits | |||
| Proceeds from sale of debt securities available for sale | |||
| Proceeds from maturities and paydowns of debt securities available for sale | |||
| Proceeds from maturities and paydowns of debt securities held to maturity | |||
| Purchases of debt securities available for sale | |||
| Net purchase of stock investments | |||
| Purchases of debt securities held to maturity | |||
| Purchases of restricted stock | |||
| Net (contributions) distributions of stock investments | |||
| Net repayment of loans | |||
| Proceeds from sale of loans held for investment | |||
| Proceeds from sales of premises and equipment | |||
| Proceeds from sale of other real estate owned | |||
| Purchases of premises and equipment | |||
| Net cash provided by investing activities | |||
| FINANCING ACTIVITIES | |||
| Net decrease in deposits | |||
| Proceeds of Federal Home Loan Bank advances | |||
| Repayment of Federal Home Loan Bank advances | |||
| Repayment of other borrowings | |||
| Proceeds from exercise of stock options | |||
| Repurchase of shares in settlement of restricted stock units | |||
| Repurchase of common stock under authorized stock repurchase program | |||
| Common stock dividends | |||
| Net cash used in financing activities | |||
| Net change in cash and cash equivalents | |||
| Cash and cash equivalents at beginning of year | |||
| Cash and cash equivalents at end of year | |||
| Supplemental Disclosures of Cash Flow Information: | |||
| Interest paid | |||
| Taxes paid (Note 11) | |||
| Lease liability arising from obtaining right-of-use assets | |||
| Loans transferred from loans held for investment to loans held for sale | |||
| Loans transferred from loans held for investment to other real estate owned | |||
| Net impact of adoption of ASU 2016-13 on retained earnings | |||
| Loan to facilitate sale of other real estate owned | |||
| Noncash or Part Noncash Acquisition, Value of Assets Acquired | |||
| Liabilities assumed in business combination (Note 2): | |||
| Fair value of net assets acquired | |||
| Fair value of stock and equity award consideration | |||
| Cash consideration | |||
| Liabilities assumed | |||
| Goodwill measurement period adjustments |
Loading...
